menu
    • menu

    Company profile for Talphera

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Talphera, Inc. is a specialized pharmaceutical company dedicated to advancing and commercializing innovative therapies tailored for use in medically supervised environments. The company's flagship product, Niyad™, is a lyophilized formulation of nafamostat, currently undergoing investigation under an investigational device exemption (IDE). Niyad™ is specifically being studied as an anticoagulant for the extracorporeal circ...
    Talphera, Inc. is a specialized pharmaceutical company dedicated to advancing and commercializing innovative therapies tailored for use in medically supervised environments. The company's flagship product, Niyad™, is a lyophilized formulation of nafamostat, currently undergoing investigation under an investigational device exemption (IDE). Niyad™ is specifically being studied as an anticoagulant for the extracorporeal circuit and has received Breakthrough Device Designation status from the FDA. In addition, Talphera is actively involved in the development of two pre-filled syringes, Fedsyra™ and PFS-02.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TalpheraUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Mateo, CA 94404
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://talphera.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/acelrx-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Talphera Reveals Q3 2025 Financials & Corporate Updates
    Talphera Reveals Q3 2025 Financials & Corporate Updates

    13 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/talphera-announces-third-quarter-2025-financial-results-and-provides-corporate-update-302613486.html

    PR NEWSWIRE
    13 Nov 2025
    Share Share
    Talphera To Host Q3 Financial Results Call On Nov 12, 2025
    Talphera To Host Q3 Financial Results Call On Nov 12, 2025

    05 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/talphera-to-host-third-quarter-financial-results-and-corporate-update-call-and-webcast-on-wednesday-november-12-2025-302604832.html

    PR NEWSWIRE
    05 Nov 2025
    Share Share
    Talphera Appoints Joe Todisco To Board Of Directors
    Talphera Appoints Joe Todisco To Board Of Directors

    21 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/talphera-announces-the-appointment-of-joe-todisco-to-board-of-directors-302589605.html

    PR NEWSWIRE
    21 Oct 2025
    Share Share
    CorMedix Announces Strategic Minority Investment in Talphera
    CorMedix Announces Strategic Minority Investment in Talphera

    08 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/08/3146092/0/en/CorMedix-Announces-Strategic-Minority-Investment-in-Talphera.html

    GLOBENEWSWIRE
    08 Sep 2025
    Share Share
    Talphera Reach 17-Patient Milestone in NEPHRO CRRT Pivotal Trial
    Talphera Reach 17-Patient Milestone in NEPHRO CRRT Pivotal Trial

    25 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/talphera-announces-achievement-of-17-patient-enrollment-milestone-in-nephro-crrt-pivotal-trial-302537148.html

    PR NEWSWIRE
    25 Aug 2025
    Share Share
    Talphera Reports Q2 2025 Financials, Updates Corporate Progress
    Talphera Reports Q2 2025 Financials, Updates Corporate Progress

    14 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/talphera-announces-second-quarter-2025-financial-results-and-provides-corporate-update-302530470.html

    PR NEWSWIRE
    14 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search